We love our bottoms-up scans here at All Star Charts. We tend to get really creative when making new universes as we want to be sure they will deliver us the best opportunities the market has to offer.
However, when it comes to our latest project, it couldn't be any simpler!
With the goal of finding more bullish setups, we have decided to expand one of our favorite scans and broaden our regular coverage of the largest US stocks.
Welcome to The Junior Hall of Famers.
This scan is composed of the next 150 largest stocks by market cap, those that come after the top 150 and are thus covered by the Hall of Famers universe. Many of these names will someday graduate and join our original Hall Of Famers list. The idea here is to catch these big trends as early on as possible.
There is no need to overcomplicate things. Market cap is a quality filter at the end of the day. It only grows if price is rising. That's good enough for us.
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a series of Form 4 filings by Gilead Sciences.
The American biopharmaceutical company revealed a purchase of roughly $320 million in Arcus Biosciences Inc $RCUS, increasing its ownership stake to 40%.
Let me remind everyone what a bad idea it is to sell naked calls.
We don't do it.
I often want to do it.
Many times, it makes sense to do it.
But the answer is always no.
It's just not worth it.
Go ask around. The old timers will tell you.
"Don't do it kid"
But that doesn't mean that as a philosophy, we shouldn't approach the market with that sort of "naked call selling" mentality, at least for the foreseeable future.
As many of you know, something we've been working on internally is using various bottom-up tools and scans to complement our top-down approach.
It's really been working for us!
One way we're doing this is by identifying the strongest growth stocks as they climb the market-cap ladder from small- to mid- to large- and, ultimately, to mega-cap status (over $200B).
Once they graduate from small-cap to mid-cap status (over $2B), they come on our radar. Likewise, when they surpass the roughly $30B mark, they roll off our list.
But the scan doesn't just end there.
We only want to look at the strongest growth industries in the market, as that is typically where these potential 50-baggers come from.
So Santa was a no-show this season. The Nasdaq 100, the S&P 500, and Papa Dow are still managing to post positive monthly returns heading into January’s close.
That's an auspicious data point for the rest of the year.
Beneath the surface, last quarter’s laggards are also playing catch up to the leadership groups…
I understand that some people are lazy and don't like to count.
I get that.
Also, journalists are NOT in the business of telling you the truth. The truth is just a commodity at this point, and that's no longer a secret. Word's gotten out. So it's either gross sensationalism or false information to get you to consume their content.
And then, of course, you have your standard charlatans who need to cherry pick data and manipulate anchor points so that they don't look as foolish for missing this entire bull market.
So what ends up happening is that if you're told something enough times, and you haven't actually done the work, you start to believe it.
"It's only Tech stocks that are driving this market"
Sound familiar?
But for those of you who actually take the time to look, you know it obviously isn't true.
We've had some great trades come out of this small-cap-focused column since we launched it back in 2020 and started rotating it with our flagship bottom-up scan, Under the Hood.
For the first year or so, we focused only on Russell 2000 stocks with a market cap between $1 and $2B.
That was fun, but we wanted to branch out a bit and allow some new stocks to find their way onto our list.
We expanded our universe to include some mid-caps.
To make the cut for our Minor Leaguers list now, a company must have a market cap between $1 and $4B.
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a series of Form 4 filings by Elias Sabo, director and CEO of Compass Group Diversified Holdings LLC $CODI.
Sabo reported an aggregate CODI purchase worth roughly $2 million.
